AMY DELUCA: Open Payments
NPI 1952888398 · CHARLTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,555 in 89 payments from 14 companies in 2025. Trend: 2023 $366 · 2024 $1,788 · 2025 $2,555
Food & beverage: $2,208Education: $347
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 12 | $556 |
| ABBVIE INC. | 16 | $379 |
| Amgen Inc. | 10 | $316 |
| GENZYME CORPORATION | 10 | $306 |
| Janssen Biotech, Inc. | 7 | $265 |
| Galderma Laboratories, L.P. | 10 | $186 |
| LEO Pharma Inc. | 6 | $177 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $114 |
| Lilly USA, LLC | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
Products named: DUPIXENT, OTEZLA, TREMFYA, SKYRIZI, NEMLUVIO, RINVOQ, ANZUPGO, Winlevi.
Industry payments across MA — which companies pay providers there.
